Cleopatra Hospital CoCAI:CLHO -1.18%88 PB Ratio is 6.48 as of Jun. 26, 2026, which is 58% above its 10-year median of 4.09. GuruFocus rates CAI:CLHO with a GF Score™ of 88/100 and a GF Value™ of E£13.82 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Cleopatra Hospital Co ranks worse than 86.42% on this metric.
Cleopatra Hospital Co stock PB Ratio (=6.01) is close to 5-year high of 6.17.
The historical rank and industry rank for Cleopatra Hospital Co's PB Ratio or its related term are showing as below:
CAI:CLHO'
s PB Ratio Range Over the Past 10 Years
Min: 2.56 Med: 4.09 Max: 10.05
Current: 6.47
During the past 11 years, Cleopatra Hospital Co's highest PB Ratio was 10.05. The lowest was 2.56. And the median was 4.09.
CAI:CLHO's PB Ratio is ranked worse than 86.42% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs CAI:CLHO: 6.47
During the past 12 months, Cleopatra Hospital Co's average Book Value Per Share Growth Rate was 19.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 28.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 13.70% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Cleopatra Hospital Co was 28.60% per year. The lowest was 0.90% per year. And the median was 12.60% per year.
Back to Basics: PB Ratio
Cleopatra Hospital Co (CAI:CLHO) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Cleopatra Hospital Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cleopatra Hospital Co PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cleopatra Hospital Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Cleopatra Hospital Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Cleopatra Hospital Co (CAI:CLHO) has a PB Ratio of 6.48 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Cleopatra Hospital Co and its competitors. This is 58% above median its historical median of 4.09. Over the past decade, Cleopatra Hospital Co's PB Ratio has ranged from 2.56 to 10.05. According to the industry distribution chart, Cleopatra Hospital Co ranks #528 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 86.4%.
Is Cleopatra Hospital Co's PB Ratio too high?
Cleopatra Hospital Co's current PB Ratio of 6.48 is 58% above median its 10-year median of 4.09. Over the past 10 years, this metric has ranged from a low of 2.56 to a high of 10.05. The Healthcare Providers & Services industry median PB Ratio is 1.98. Cleopatra Hospital Co's value of 6.48 is 227.3% above this industry median. Based on the distribution chart, Cleopatra Hospital Co ranks #528 out of 611 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Cleopatra Hospital Co has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cleopatra Hospital Co's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cleopatra Hospital Co ranks #528 out of 611 companies for PB Ratio. This places Cleopatra Hospital Co in the lower half of its industry. The industry median PB Ratio is 1.98. Cleopatra Hospital Co's value of 6.48 is 227.3% above this benchmark. Historically, Cleopatra Hospital Co's own PB Ratio has ranged from 2.56 to 10.05 over the past decade. While the company's 10-year median is 4.09 vs. the industry median of 1.98, Cleopatra Hospital Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cleopatra Hospital Co's current PB Ratio of 6.48 is 227.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Cleopatra Hospital Co and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cleopatra Hospital Co's current PB Ratio is 6.48, which is 58% above median its own 10-year median of 4.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleopatra Hospital Co stock overvalued right now?
Based on GuruFocus' analysis, Cleopatra Hospital Co (CAI:CLHO) is currently considered Modestly Overvalued. The stock's GF Value™ is E£13.82, compared to a current price of E£16.80 — trading 21.6% above its estimated fair value. The current PB Ratio is 6.48, which is 58% above median its 10-year median of 4.09 and 227.3% above the Healthcare Providers & Services industry median of 1.98. Cleopatra Hospital Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Cleopatra Hospital Co (CAI:CLHO), the current PB Ratio is 6.48 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cleopatra Hospital Co (CAI:CLHO) Overvalued in 2026?
Based on GuruFocus' analysis, Cleopatra Hospital Co stock appears to be overvalued.
The current stock price of E£16.80 is trading 21.6% above its estimated GF Value™ of E£13.82.
GuruFocus considers Cleopatra Hospital Co to be Modestly Overvalued.
Key valuation signals for CAI:CLHO:
PB Ratio: 6.48 (58% above median its 10-year median of 4.09)
GF Value™: E£13.82 vs. price of E£16.80 (21.6% above fair value)
Industry Position: 227.3% above the Healthcare Providers & Services median (#528 of 611)
No single metric tells the full story. See the CAI:CLHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company's segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.
88GF Score
Get the complete analysis for CAI:CLHO
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:CLHO has been successfully added to your 
